Introduction: Infection is the leading cause of complications in critically ill, and its presence signifi cantly infl uences the treatment outcome. Empirical antibiotic therapy (EAT) is justifi ed if limited to the time required for isolation and identifi cation of pathogen, which is considered not to exceed 72 hours. Aim: The aim of this study was to determine the rate of prolonged empirical antibiotic therapy (PEAT) in adult intensive care unit (ICU) -treated patients at the third level hospital and to assess factors infl uencing the antibiotic prescription practice in the hospital. The study also aimed to assess in-hospital mortality in patients treated with empirical antibiotic therapy (EAT) and to fi nd parameters that were associated with fatal outcome. Subjects and Methods: Prospective observational study involved 51 consecutive patient who underwent EAT. Demographic, clinical and laboratory data were collected. The rate of PEAT was determined as the ratio of the total number of patients who received EAT longer than 72 hours divided by the total number of patients who received EAT regardless the length of its duration. Results: The rate of PEAT was 80%. In patients with diagnosed infection, length of EAT depended on the time needed for bacteria isolation. However, EAT was introduced and even prolonged in 33% of patients, in which infection was never confi rmed. In-hospital mortality was 20%, and factors associated with death outcome were ongoing sepsis and longer EAT. Conclusions: The practice of prescribing prolonged antibiotic therapy is very common in this study. This is associated with higher mortality, so it is necessary to fi nd the cost-eff ective diagnostic method that helps in adjustment of rational empirical antibiotic treatment in ICU.
INTRODUCTION
Infection is the leading cause of complications in critically ill, and its presence signifi cantly infl uences the treatment outcome [1] . Clinical features (fever, fatigue, muscle aches) and biomarkers of bacterial infection (e.g. WBC, CRP, and PCT) are more or less specifi c and are oft en altered in critically ill [2, 3] . Accordingly, diagnosis of infection relies mostly on positive microbiological cultures. Considering time-consuming conventional culture-based methods, empirical therapy is oft en the only option as delayed antibiotic therapy is associated with worse outcome [4, 5] . Empirical antibiotic therapy (EAT) is justifi ed if limited to the time required for isolation and identifi cation of pathogen, which is considered not to exceed 72 hours [6] [7] [8] Any further use of antibiotics is considered prolonged. High incidence of a diagnostically challenging disease with signifi cant mortality, leads to widespread use of antibiotics in intensive care unit (ICU) [9] . Moreover, antibiotics are initiated four times more than the infection is confi rmed, and are frequently given longer than necessary [6, 10] .
Current guidelines for treatment of infection are rigid and do not take interhospital diff erences and the local epidemiological situation into account. Th erefore, treating patients in Europe according to the well-established American guidelines, and vice versa, is potentially inadequate. Moreover, there are diff erences among the guidelines for antibiotic therapy. Usually, a consensus should be reached among diff erent specialists in ICU (e.g. anesthesiologists, clinical pharmacologists, and surgeons) regarding the most appropriate treatment of infections in critically ill.
AIM
Th e aim of this study was to determine the rate of prolonged empirical antibiotic therapy (PEAT) in adult ICU-treated patients at the third level hospital. In addition, we aimed at assessing factors infl uencing the antibiotic prescription practice in the hospital. Finally, the aim was to assess in-hospital mortality in patients treated with EAT and to fi nd parameters that were associated with fatal outcome. Our study could be used as a model for similar health care establishments in developing countries.
SUBJECTS AND METHODS
Academic, prospective, observational study was performed at the Clinical Center "Bezanijska kosa" (BK), Belgrade, within the period from April 1 st to June 30 th , 2016. Th e study was approved by the Ethics Committee of the BK (Ethical approval number 2722/4, from 7 th April 2016). Criteria for inclusion were: 1) hospitalization in ICU at BK during observed period, 2) course of empirical antibiotic therapy regardless indication. Patients receiving antibiotics for confi rmed infection or surgical prophylaxis were excluded from the study. ICU has a total capacity of 14 beds. Demographic, clinical and laboratory data were collected.
Th e suspicion of infection was based on a clinical features (fever, fatigue, muscle aches) and biochemical markers of bacterial infection (WBC, CRP, and PCT). Before initiation of antibiotic treatment, microbiological samples were collected from patients. Defi nitive diagnosis was based on microbiological isolation and identifi cation. Th e identifi cation of isolated cultures of bacteria and susceptibility testing was performed by Vitek 2 system (bioMérieux, Mercy l'Etoile, France) according to the manufacturer's guidelines (Vitek 2 Compact S/N VK2C-2796 Systems Version: 07.01. Firmware BCB: 1.11; MIC Interpretation Guideline: CLSI+Phenotypic).
Empirical antibiotic therapy (EAT) was defi ned as the use of antibiotics in the treatment of a suspected infection, given prior to the identifi cation of pathogen [11] . If EAT is continued over 72 hours without defi nitive diagnosis of infection it is considered prolonged [6] . Rate of prolonged empirical antibiotic therapy (PEAT) is determined as the ratio of the total number of patients who received empiric antibiotics longer than 72 hours divided by the total number of patients who received EAT regardless the length of her duration.
Criteria from the Sanford Guide to Antimicrobial Th erapy [12] were used by two independent experts, clinical pharmacology specialists, to evaluate the appropriateness of EAT. Appropriate EAT implies that the route, dosage and choice of antibiotic was according guidelines for given indication.
Patients admitted to ICU for urgent surgery, as well as patients transferred from another medical ward due to clinical deterioration, were considered critically ill.
Clinical outcome was discharge sta-tus, i.e. death or hospital discharge. Statistical analyses were performed using R, version 3.3.2. Data were analyzed by descriptive statistics (frequency, mean values ± standard deviation, median and interquartile range of 25-75%). Associations between potential risk factors and an outcome were tested using the parametric and nonparametric statistical tests (chi square test, Mann Whitney U-test, and Student's t-test), at the statistical signifi cance level p < 0.05. Logistic regression was not performed due to the small sample size versus the number of predictors' , as the results of the test would not be reliable.
RESULTS
In total, we collected medical records of 51 consecutive ICU patients subjected to EAT during three-month period. Clinical and epidemiological data of patients treated with EAT Table 1 .
Th e youngest patient was 21, and the oldest was 87 years old (mean 68.43 ± 13.09 years). Median lengths of EAT and hospitalization were 6 days and 13 days, respectively. Rate of PEAT was 80%, i. e. empirical therapy was prolonged in 41/51 patients.
Indicators of infection: biomarkers, clinical symptoms and microbiological confi rmation were present in 51% (26/51), 80% (41/51) and 67% (34/51) patients, respectively. In patients with defi nitive diagnosis of infection, median length of hospitalization (LoH) before isolation of bacteria was 5 days.
Appropriate EAT was initiated in 33% (17/51) patients.
Suspicion of sepsis was indication for initiating EAT in 22% (11/51) patients. All patients treated for sepsis had microbiologically confi rmed infection.
Most of the patients had one or more associated diseases that could lead to worse outcome. Common comorbidities were: arterial hypertension (65%), malignancy (35%) and diabetes mellitus (22%). Total study population was divided into three subgroups according to defi nitive identifi cation of microorganisms and the clinical outcome (groups A, B and C, respectively, for details see Fig. 1 ).
Comparison of demographic and clinical characteristics of patients with confi rmed infection (group A+B) with patients without confi rmed infection (group C) showed no signifi cant diff erence between groups, except in biomarkers of bacterial infection (WBC, CRP, and PCT), which were more frequently changed in patients with confi rmed infection (χ2, p < 0.05) ( Table 2) .
Sepsis was indication for initiation of EAT only in patients with confi rmed infection. No other diff erences were seen between these groups.
During the follow-up period, 10 out of 51 patients died, with calculated in-hospital mortality of 20% (Table 1 ). All fatal outcomes were recorded in group with proven infection, while all patients without microbiological confi rmation were discharged from hospital. In order to assess predictors of inhospital mortality, potential risk factors are compared only among patients with confi rmed infection (Table 3) .
Th ere was no signifi cant correlation between the age of patients and clinical outcome (Mann Whitney U-test, p > 0.05). Total LoH did not aff ect mortality (Mann-Whitney U test, p > 0.05, both). Based on results obtained from these two groups, strong positive linear correlation between length of EAT and LoH before isolation of bacteria was shown (r = 0.97, p<0.001, Spearman's rank correlation coeffi cient). LoH before isolation of bacteria was signifi cantly longer in patients who died (p < 0.05, Mann-Whitney U test). Accordingly, length of EAT was signifi cantly longer in patients in group A than in B (p < 0.05, Mann- can guidelines, EAT is justifi ed if introduced based on clinical presentation, experience of clinicians and local resistance patterns [7, 11] . It should be limited to the time required for identifi cation of pathogen and susceptibility testing. It is believed that seventy-two hours are an acceptable time frame for pathogen detection in conventional culture [6] . Any further use of antibiotics in the absence of confi rmed infection is considered inappropriate and could lead to adverse clinical and microbiological outcomes (for example, increased mortality and spread of multidrug-resistant bacteria in clinical settings) [10] . Antibiotic use in our study was adjusted to these principles -length of the EAT was directly dependent on the LoH before isolation of the bacteria. However, time necessary for isolation was long, with median value of 6 days. Consequently, this resulted in a high rate of PEAT, which was 80% in the study. Th e main reason for the application of PEAT, in groups with confi rmed infection (A and B), is extended time of hospitalization before isolation of bacteria. We cannot determine with certainty whether this is due to prolonged isolation time or failure of attending physician to provide adequate sample. Of note, 33% of patients (17/51) without confi rmed infection received EAT. Th ere was no diff erence in length of EAT in this group compared to patients with confi rmed infection. Similar observations were Whitney U test).
Characteristic clinical symptoms and biomarkers of bacterial infection (WBC, CRP, and PCT) were recorded in both groups, but there was no signifi cant diff erence between patients who survived, and those who did not (χ2, p > 0.05, both).
Appropriate EAT, defi ned as a use of antibiotic appropriate for the indication, did not aff ect the outcome (χ2, p > 0.05). But it is important to emphasize that the prescription of EAT was appropriate in less than a half of patients in both groups.
Sepsis was more oft en indication for initiation of EAT in Group A than in B (χ2, p < 0.05), that is, sepsis was associated with mortality.
Presence of critical illness was not related to the more frequent occurrence of a particular outcome (χ2, p > 0.05). Similar results are obtained for the presence of individual comorbidity (χ2, p > 0.05, each separately).
DISCUSSION
Our study was conducted in the university medical center in Belgrade. To our knowledge, there are no published results about the empirical use of antibiotics in Serbia and the Region. In total, we collected medical records of 51 consecutive ICU patients subjected to EAT during three-month period.
According to European and Ameri- made in other studies conducted in the ICUs [2, 6] . Even though previous studies showed that PEAT in patients without infection is not independently associated with mortality, this practice is unjustifi ed and potentially harmful [10] . In present study, the only characteristics that distinguished patients with not-confi rmed infection from those with confi rmed infection were presence of biomarkers of the infection, which primarily refers to elevated PCT values. Th is fi nding is concordant with studies which suggest that PCT is most specifi c biomarker when determining presence or absence of bacterial infection [13] [14] [15] . In one-third of this study population, EAT was introduced based on the clinical symptoms and non-specifi c biomarkers of infection (WBC, CRP) which are frequently changed in critically ill. PCT is not routinely measured because the test is high-priced, signifi cantly more than CRP and blood counts. However, recently conducted cost-eff ectiveness analysis showed that PCT guided antibiotic therapy leads to reduced number of patients receiving antibiotics, reduced antibiotic duration, reduced hospital and ICU stay, with no diff erences for adverse clinical outcomes [16] . Consequent reduction in the total cost was result of all reductions mentioned above. It is necessary to consider the routine use of the PCT as a marker that will more accurately, potentially without increasing costs, diff erentiate patients with infection from the ones without.
Another important measured outcome was in-hospital mortality, which reached 20% (10/51) in our study population. Examination of demographic and clinical characteristics according to our aims shows that there was no fatal outcome in a group without microbiological confi rmation of infection. Th erefore, assessment of potential mortality risk factors was made only among patients with confi rmed infection. Two major observations were made: patients who died had significantly longer hospitalization before bacterial isolation and longer EAT than discharged patients. Although EAT was signifi cantly longer in patients with fatal outcome than in group of patients who were discharged, empirical use of antibiotics in both groups was longer than recommended in current guidelines.
We further found that sepsis was an independent variable associated with increased mortality. Sepsis is one of the most common indications for the introduction of EAT in ICU, and also among the leading causes of death with a mortality rate of 27% to 54% [17] . Introduction of EAT within the fi rst hour of sepsis onset is associated with increased survival to hospital discharge [18] . Antibiotics for treatment of sepsis were timely administered in the study. Th e basic principle of EAT involves changing broad-spectrum antimicrobial to a narrow-spectrum antimicrobial therapy, based on culture results [17] . Infection was microbiologically confi rmed in all patients with sepsis, but as the EAT was prolonged, broad-spectrum antibiotics were longer used. No diff erence in mortality depending on the treatment (broad-spectrum or narrowspectrum antibiotics therapy) is proven [17] . Nevertheless, therapy should be switched to a narrow-spectrum antibiotic, since it allows an opportunity to limit overuse of broad-spectrum antibiotics, thereby reducing the costs and preventing resistance development.
Besides timely initiated EAT, appropriate EAT signifi cantly reduces mortality in patients with sepsis, regardless the cause of the infection [19] . According to fi ndings in this study, death outcome in patients receiving appropriate EAT was as frequent as in those receiving inappropriate EAT. According to Kariv et al., the pooled rate of inappropriate EAT is about 30%, although the rates in individual studies were highly variable (calculated from 87 prospective studies with more than 27,000 patients) [20] . However, the frequency of inappropriate EAT in this study is very high, close to 70%. Knowing local resistance map along with development of guidelines with the most appropriate empiric antibiotic treatment for each indication could possibly help in overcoming this problem. Medical students, medical doctors, specialists education specifi cally focused on prescription errors may contribute to improvement of antibiotic prescribing competence. Th e role of Hospitals clinical pharmacology units would be of clinical help [21, 22] . Limitation of the study is a small sample size. Th erefore, false negative results could be expected and conclusions should be taken with reserve.
CONCLUSION
Despite the timely initiated EAT in our study, its duration was longer than recommended in current guidelines. Estimated rate of PEAT 17. Silva BN, Andriolo RB, Atallah AN, Salomão R. De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock.
is 80%, and prolongation of EAT in patients with confi rmed infection directly depends on LoH before isolation of bacteria. Further, it is important to emphasize that in one-third of this study population, infection was never confi rmed, but EAT was introduced and even prolonged. Elevated PCT values were only characteristic that distinguished patients with confi rmed from those with not-confi rmed infection.
In-hospital mortality was 20%, and assessment of potential mortality risk factors showed that ongoing sepsis and longer EAT were associated with mortality.
It is necessary to evaluate the cost-effectiveness of methods with higher sensitivity and specifi city to detect infection, in order to shorten the duration of empirical therapy and decrease the likelihood of prescribing PEAT in the absence of infection. Th is is a critical issue because the long-term and inadequate use of antibiotics is related with worse outcome.
